Synonym: N,N′′′-[(1,1-Dioxido-2H-1,2,4,6-thiatriazine-3,5-diyl)bis(2,1-ethanediylthiomethylene-4,2-thiazolediyl)]bisguanidine; 3,5-Bis[2-[[[2-[(diaminomethylene)amino]thiazol-4-yl]methyl]sulphanyl]ethyl]-4H-1,2,4,6-thiatriazine 1,1-dioxide
CAS Number: 89268-62-2
Empirical Formula (Hill Notation): C16H23N11O2S5
Molecular Weight: 561.75
Linear Formula: C16H23N11O2S5
Product Type: Chemical
| agency |
USP |
| API family |
famotidine |
| application(s) |
pharmaceutical (small molecule) |
| biological source |
synthetic |
| color |
yellow to white |
| form |
powder |
| format |
neat |
| grade |
pharmaceutical primary standard |
| InChI |
1S/C16H23N11O2S5/c17-13(18)24-15-21-9(7-32-15)5-30-3-1-11-23-12(27-34(28,29)26-11)2-4-31-6-10-8-33-16(22-10)25-14(19)20/h7-8H,1-6H2,(H,23,26,27)(H4,17,18,21,24)(H4,19,20,22,25) |
| InChI key |
NRRXZFHNRLQONH-UHFFFAOYSA-N |
| manufacturer/tradename |
USP |
| packaging |
pkg of 25 mg |
| solubility |
water: soluble |
| storage condition |
protect from light |
| Analysis Note: |
These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
| Application: |
Famotidine Related Compound B can be used as a pharmaceutical primary standard for the determination of the analyte in pharmaceutical formulations by various analytical techniques. |
| General description: |
Famotidine Related Compound B (Famotidine Impurity B) is an impurity of famotidine, which is a hydrophilic, cationic, histamine H2 receptor antagonist drug that effectively inhibits gastric acid secretion in humans. |
| Other Notes: |
Sales restrictions may apply. |
| RIDADR |
NONH for all modes of transport |
| WGK Germany |
WGK 3 |
| Flash Point(F) |
Not applicable |
| Flash Point(C) |
Not applicable |
